Announcements Trials
Browse Landscape

Status

Available 1

Sponsor Class

INDUSTRY 1

Study Type

Expanded_access 1

Sponsor

Cancer Type

Gastrointestinal 6Sarcoma 1Lymphoid 1Gynecologic 1Genitourinary 1CNS 1Breast 1

Conditions

Stomach Neoplasms 1Sarcoma 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Neoplasms 1Lymphoma, Non-Hodgkin 1Hodgkin Disease 1Glioblastoma 1Carcinoma, Squamous Cell 1Breast Neoplasms 1Brain Neoplasms 1

Interventions

Cisplatin 5Carboplatin 5Cyclophosphamide 4Bevacizumab 4130-nm albumin-bound paclitaxel 4pembrolizumab 3Oxaliplatin 3Magnetic Resonance Spectroscopy 3Leucovorin 3Irinotecan 3Gemcitabine 3Fluorouracil 3Docetaxel 3Capecitabine 3tislelizumab 2fludarabine 2Specimen Handling 2Riluzole 2Quality of Life 2Psychiatric Rehabilitation 2Oncolytic Virotherapy 2Observation 2Fluorodeoxyglucose F18 2Fluorescein 2Floxuridine 2Filgrastim 2Drug Therapy 2Cetuximab 2umbralisib 1trifluridine tipiracil drug combination 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Stomach Neoplasms × Proton Pump Inhibitors × Sarcoma × Clear all
NCT05974410 2025-10-02

Expanded Access to Immunomodulatory AVM0703 for Solid Tumor and Blood Cancer Patients

AVM Biotechnology Inc

Available
BreastCNSGastrointestinalGenitourinaryGynecologicLymphoidSarcoma

Brain Neoplasms, Breast Neoplasms, Carcinoma, Squamous Cell, Glioblastoma, Hodgkin Disease, Lymphoma, Non-Hodgkin, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Sarcoma, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡